0.1.0 - ci-build

oncologyfhirigkenya - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Tumor Markers - JSON Representation

Active as of 2025-06-24

Raw json | Download

{
  "resourceType" : "CodeSystem",
  "id" : "tumor-markers",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem tumor-markers</b></p><a name=\"tumor-markers\"> </a><a name=\"hctumor-markers\"> </a><p>This case-sensitive code system <code>http://example.org/fhir/CodeSystem/tumor-markers</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">CEA<a name=\"tumor-markers-CEA\"> </a></td><td>Carcinoembryonic Antigen</td></tr><tr><td style=\"white-space:nowrap\">AFP<a name=\"tumor-markers-AFP\"> </a></td><td>Alpha-fetoprotein</td></tr><tr><td style=\"white-space:nowrap\">PSA<a name=\"tumor-markers-PSA\"> </a></td><td>Prostate-Specific Antigen</td></tr><tr><td style=\"white-space:nowrap\">CA125<a name=\"tumor-markers-CA125\"> </a></td><td>Cancer Antigen 125</td></tr><tr><td style=\"white-space:nowrap\">CA15_3<a name=\"tumor-markers-CA15_3\"> </a></td><td>Cancer Antigen 15-3</td></tr><tr><td style=\"white-space:nowrap\">CA19_9<a name=\"tumor-markers-CA19_9\"> </a></td><td>Cancer Antigen 19-9</td></tr><tr><td style=\"white-space:nowrap\">LDH<a name=\"tumor-markers-LDH\"> </a></td><td>Lactate Dehydrogenase</td></tr><tr><td style=\"white-space:nowrap\">hCG<a name=\"tumor-markers-hCG\"> </a></td><td>Human Chorionic Gonadotropin</td></tr><tr><td style=\"white-space:nowrap\">B2M<a name=\"tumor-markers-B2M\"> </a></td><td>Beta-2 Microglobulin</td></tr></table></div>"
  },
  "url" : "http://example.org/fhir/CodeSystem/tumor-markers",
  "version" : "0.1.0",
  "name" : "TumorMarkers",
  "title" : "Tumor Markers",
  "status" : "active",
  "experimental" : false,
  "date" : "2025-06-24T09:16:08+00:00",
  "publisher" : "Medby_Tech",
  "contact" : [
    {
      "name" : "Medby_Tech",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://example.org/example-publisher"
        }
      ]
    }
  ],
  "description" : "Tumor markers commonly used in oncology diagnostics and monitoring in Kenya.",
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 9,
  "concept" : [
    {
      "code" : "CEA",
      "display" : "Carcinoembryonic Antigen"
    },
    {
      "code" : "AFP",
      "display" : "Alpha-fetoprotein"
    },
    {
      "code" : "PSA",
      "display" : "Prostate-Specific Antigen"
    },
    {
      "code" : "CA125",
      "display" : "Cancer Antigen 125"
    },
    {
      "code" : "CA15_3",
      "display" : "Cancer Antigen 15-3"
    },
    {
      "code" : "CA19_9",
      "display" : "Cancer Antigen 19-9"
    },
    {
      "code" : "LDH",
      "display" : "Lactate Dehydrogenase"
    },
    {
      "code" : "hCG",
      "display" : "Human Chorionic Gonadotropin"
    },
    {
      "code" : "B2M",
      "display" : "Beta-2 Microglobulin"
    }
  ]
}